Debenzergoline

Debenzergoline, or propyldebenzergoline, is a dopamine receptor agonist and partial ergoline.^[1][2] It is an analogue of ergoline in which the A ring of the ergoline ring system has been removed.^[1][2] The drug strongly inhibits prolactin secretion and produces antiparkinsonian effects in rodents.^[1][2] Debenzergoline was first described in the scientific literature by 1980.^[1][2]

Other namesPropyldebenzergoline

Drug classDopamine receptor agonist

ATC code

• None

PubChem CID

• 12902677

Quick facts Clinical data, Other names ...

Debenzergoline

Clinical data
Other names	Propyldebenzergoline
Drug class	Dopamine receptor agonist
ATC code	None
Identifiers
IUPAC name trans-(±)-2,3,4,4a,5,7,9,9a-octahydro-1-propyl-1H-pyrrolo[3,4-g]quinoline
PubChem CID	12902677
ChemSpider	96353452
Chemical and physical data
Formula	C14H22N2
Molar mass	218.344 g·mol−1
3D model (JSmol)	Interactive image
SMILES C1C2CC3=CN([H])C=C3C[C@@]2([H])N(CCC)CC1
InChI InChI=1S/C14H22N2/c1-2-5-16-6-3-4-11-7-12-9-15-10-13(12)8-14(11)16/h9-11,14-15H,2-8H2,1H3/t11?,14-/m1/s1 Key:QLJJALZPNURUSU-SBXXRYSUSA-N

Close